Cargando…
Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
INTRODUCTION: Melanoma is a highly aggressive malignant skin tumor as well as the primary reason for skin cancer‐specific deaths. We first identified immune‐related long noncoding RNA (lncRNA) prognostic signature and found potential immunotherapeutic targets for melanoma cancer. METHODS: RNA‐seq da...
Autores principales: | Xiao, Bo, Liu, Liyan, Li, Aoyu, Wang, Pingxiao, Xiang, Cheng, Li, Hui, Xiao, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342236/ https://www.ncbi.nlm.nih.gov/pubmed/34077998 http://dx.doi.org/10.1002/iid3.468 |
Ejemplares similares
-
Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma
por: Xiao, Bo, et al.
Publicado: (2020) -
Identification of Epithelial–Mesenchymal Transition-Related Prognostic lncRNAs Biomarkers Associated With Melanoma Microenvironment
por: Xiao, Bo, et al.
Publicado: (2021) -
Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma
por: Ping, Shuai, et al.
Publicado: (2021) -
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021) -
A Novel Overall Survival Prediction Signature Based on Cancer Stem Cell-Related Genes in Osteosarcoma
por: Xiao, Bo, et al.
Publicado: (2021)